IRIS
MONTOMOLI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.121
EU - Europa 16.357
AS - Asia 8.547
SA - Sud America 1.713
Continente sconosciuto - Info sul continente non disponibili 589
AF - Africa 389
OC - Oceania 29
Totale 44.745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.802
GB - Regno Unito 4.998
RU - Federazione Russa 2.897
IT - Italia 2.744
CN - Cina 2.713
SG - Singapore 2.632
IE - Irlanda 1.762
BR - Brasile 1.423
VN - Vietnam 976
UA - Ucraina 838
SE - Svezia 785
FR - Francia 775
HK - Hong Kong 715
DE - Germania 651
KR - Corea 459
FI - Finlandia 416
IN - India 266
BD - Bangladesh 211
ZA - Sudafrica 150
CA - Canada 148
AR - Argentina 120
MX - Messico 90
NL - Olanda 85
IQ - Iraq 84
TR - Turchia 68
ES - Italia 67
AT - Austria 66
PL - Polonia 63
JP - Giappone 53
NG - Nigeria 53
CI - Costa d'Avorio 49
ID - Indonesia 46
PK - Pakistan 41
BE - Belgio 39
EC - Ecuador 38
UZ - Uzbekistan 35
MA - Marocco 32
CO - Colombia 31
CZ - Repubblica Ceca 29
KE - Kenya 29
AU - Australia 26
LT - Lituania 24
SA - Arabia Saudita 24
VE - Venezuela 24
MY - Malesia 21
JM - Giamaica 20
PE - Perù 20
JO - Giordania 19
PH - Filippine 19
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
CL - Cile 17
EG - Egitto 15
IL - Israele 15
TH - Thailandia 14
CH - Svizzera 13
TN - Tunisia 13
UY - Uruguay 13
AZ - Azerbaigian 12
BG - Bulgaria 12
DZ - Algeria 12
IR - Iran 12
OM - Oman 12
CR - Costa Rica 11
HU - Ungheria 10
KG - Kirghizistan 9
NP - Nepal 9
PT - Portogallo 9
AL - Albania 8
KZ - Kazakistan 8
LB - Libano 8
DK - Danimarca 7
GR - Grecia 7
LV - Lettonia 7
RO - Romania 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BH - Bahrain 6
BO - Bolivia 6
ET - Etiopia 6
GT - Guatemala 6
HN - Honduras 6
KH - Cambogia 6
PA - Panama 6
SN - Senegal 6
SV - El Salvador 6
BY - Bielorussia 5
CG - Congo 5
LU - Lussemburgo 5
SC - Seychelles 5
BB - Barbados 4
DO - Repubblica Dominicana 4
EU - Europa 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
Totale 44.097
Salva come PNG Salva come JPEG
Città #
Southend 4.623
Dallas 2.263
Dublin 1.743
Fairfield 1.471
Singapore 1.344
Ashburn 1.255
Chandler 988
Santa Clara 901
Moscow 809
Woodbridge 710
Milan 695
Jacksonville 686
Hong Kong 679
Houston 604
Beijing 597
San Jose 575
Wilmington 569
Seattle 563
Hefei 558
Council Bluffs 510
Cambridge 470
Siena 441
Seoul 437
Ann Arbor 406
The Dalles 290
Princeton 282
Los Angeles 277
Ho Chi Minh City 266
Rome 266
Nanjing 229
Lauterbourg 214
Hanoi 198
Helsinki 192
Dong Ket 189
New York 163
Munich 145
Buffalo 132
Johannesburg 126
Columbus 121
San Diego 119
San Mateo 118
Boardman 117
São Paulo 109
Florence 91
Lappeenranta 85
Orem 77
Nanchang 74
Bengaluru 73
Redondo Beach 71
Shanghai 64
London 63
North Bergen 63
Figino 59
Chicago 55
Nuremberg 55
Shenyang 55
Phoenix 54
Tianjin 52
Toronto 51
Abidjan 49
Frankfurt am Main 49
Mumbai 49
Abuja 48
Warsaw 47
Tokyo 46
Da Nang 45
Baghdad 44
Rio de Janeiro 44
Hebei 42
Changsha 39
Vienna 38
Brussels 37
Chennai 37
Montreal 37
Málaga 37
Kunming 36
Atlanta 35
Brooklyn 35
Jiaxing 33
Amsterdam 31
Stockholm 31
Hangzhou 30
San Francisco 30
Turin 30
Belo Horizonte 29
Guangzhou 29
Haiphong 29
Jinan 29
Norwalk 29
Boston 28
Brasília 27
Brescia 27
Denver 27
Tashkent 27
Dearborn 25
Dhaka 25
Portsmouth 24
Düsseldorf 23
Turku 23
Mexico City 22
Totale 29.894
Salva come PNG Salva come JPEG
Nome #
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses 641
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 640
The virucidal potential effects of violet-blue light on influenza D virus 566
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 547
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 512
Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains 500
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 486
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 463
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 428
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 373
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 353
Egg-Independent Influenza Vaccines and Vaccine Candidates 332
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice 320
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 302
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 298
A method for detection of neuraminidase antibody in serum 291
Flucelvax (Optaflu) for seasonal influenza 282
Challenges in the development of egg-independent vaccines for influenza 279
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 274
Emerging influenza strains in the last two decades: A threat of a new pandemic? 271
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines 266
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination 263
Influenza immunology evaluation and correlates of protection: a focus on vaccines 262
Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects 262
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 261
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults 261
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 260
N. meningitidis and TLR polymorphisms: A fascinating immunomodulatory network 259
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season 257
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 253
An unwanted guest: Neisseria meningitidis–carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence 251
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy 251
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season 248
How much ozone bactericidal activity is compromised by plasma components? 246
Neisseria meningitidis infection: Who, when and where? 244
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 243
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 242
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 240
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols 237
Early rise of blood T follicular helper cell subsets and baseline immunity as predictors of persisting late functional antibody responses to vaccination in humans 235
Impact of erythrocyte species on assays for influenza serology 235
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 235
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 233
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 231
RT-PCR multiplex per l’identificazione simultanea di influenza virus A/H1N1 A/H3N2 e B e Virus Respiratorio Sinciziale di tipo A e B 229
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine 229
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses 228
Cost-benefit evaluation of anti-influenza vaccination in the elderly during two influenza seasons in the Siena district [Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella provincia di Siena] 227
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study 223
A Cell Culture (Vero)–Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses 223
Fighting Neisseria meningitidis: past and current vaccination strategies 221
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 219
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 219
CORRELATES OF PROTECTION AND HOST-RELATED MODIFIERS OF THE IMMUNOGENICITY OF INFLUENZA VACCINES: EVIDENCE MAPS AND EVIDENCE GAPS 218
Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines 216
Influenza vaccines: Evaluation of the safety profile 213
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture 211
Measles in pregnancy: a threat for Italian women? 209
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza 205
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 205
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 204
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses 204
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 201
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? 200
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge 200
Controllo dell'attività sterilizzante di un nuovo tipo di autoclave per uso odontoiatrico. 199
Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period 197
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 195
Live attenuated influenza vaccine in children induces b-cell responses in tonsils 195
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 195
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 194
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 193
Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence 192
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy 191
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial 191
Chlamydia pneumoniae and angiographically demonstred coronary artery disease in sample population from Italy 191
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 190
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response 190
Valutazione benefici/costi della vaccinazione antinfluenzale negli anziani 190
Pre-emptive vaccination against pandemic influenza virus 189
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 189
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 189
Vaccination against Hepatitis B - Lenght of protection among populations at risk 188
Hepatitis A infection in central Tuscany in children and youths 186
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 186
Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals 186
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania 186
Water and air ozone treatment as an alternative sanitizing technology 183
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine 183
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 182
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus 182
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 181
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 180
Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) 180
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations 180
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 179
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE 178
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 176
Trend of accesses to the ED of Teaching Hospital of Tuscany for bronchiolitis 2018-2023: new emergency 176
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap? 176
Totale 25.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.417 0 394 263 233 100 75 115 174 164 214 225 460
2022/20233.333 201 296 402 480 311 666 90 299 344 62 111 71
2023/20242.547 86 75 187 110 101 589 981 75 27 111 38 167
2024/20256.417 160 386 611 352 727 424 221 368 569 286 652 1.661
2025/202616.090 1.271 2.069 2.031 1.866 2.630 611 1.576 475 660 955 629 1.317
2026/2027993 925 68 0 0 0 0 0 0 0 0 0 0
Totale 44.745